73731-86-9 Usage
General Description
Broussonin B is a chemical compound isolated from the leaves of the plant Broussonetia kazinoki. It is a flavonoid with potential therapeutic properties. Studies have shown that Broussonin B possesses anti-inflammatory, antioxidant, and anti-cancer activities. It has been found to inhibit the growth of various cancer cell lines, including lung, liver, and breast cancer cells. Broussonin B also exhibits protective effects against oxidative stress-induced cell damage. Its anti-inflammatory properties make it a potential candidate for the treatment of inflammatory diseases. Overall, Broussonin B is a promising compound with diverse biological activities and potential applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 73731-86-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,7,3 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 73731-86:
(7*7)+(6*3)+(5*7)+(4*3)+(3*1)+(2*8)+(1*6)=139
139 % 10 = 9
So 73731-86-9 is a valid CAS Registry Number.
73731-86-9Relevant articles and documents
Concise synthesis of broussonone A
Jo, Hyeju,Choi, Minho,Viji, Mayavan,Lee, Young Hee,Kwak, Young-Shin,Lee, Kiho,Choi, Nam Song,Lee, Yeon-Ju,Lee, Heesoon,Hong, Jin Tae,Lee, Mi Kyeong,Jung, Jae-Kyung
, p. 15966 - 15975 (2015/12/01)
A concise and expeditious approach to the total synthesis of broussonone A, a p-quinol natural compound, has been developed. The key features of the synthesis include the Grubbs II catalyst mediated cross metathesis of two aromatic subunits, and a chemoselective oxidative dearomatizationin the presence of two phenol moieties. Especially, optimization associated with the CM reaction of ortho-alkoxystyrenes was also studied, which are known to be ineffective for Ru-catalyzed metathesis reactions under conventional reaction conditions because ortho-alkoxy group could coordinate to the ruthenium center, resulting in the potential complication of catalyst inhibition.